225 related articles for article (PubMed ID: 12402232)
1. [Neuropharmacology and receptor studies in the elderly].
Meltzer CC
Rev Neurol; 2002 Oct 16-31; 35(8):767-77. PubMed ID: 12402232
[TBL] [Abstract][Full Text] [Related]
2. Neuropharmacology and receptor studies in the elderly.
Meltzer CC
J Geriatr Psychiatry Neurol; 1999; 12(3):137-49. PubMed ID: 10593702
[TBL] [Abstract][Full Text] [Related]
3. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.
Meltzer CC; Smith G; DeKosky ST; Pollock BG; Mathis CA; Moore RY; Kupfer DJ; Reynolds CF
Neuropsychopharmacology; 1998 Jun; 18(6):407-30. PubMed ID: 9571651
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography imaging of the aging brain.
Meltzer CC; Becker JT; Price JC; Moses-Kolko E
Neuroimaging Clin N Am; 2003 Nov; 13(4):759-67. PubMed ID: 15024959
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
Kegeles LS; Mann JJ
Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
[TBL] [Abstract][Full Text] [Related]
6. TechSight. Imaging. A molecular map for neurodegeneration.
Marek K; Seibyl J
Science; 2000 Jul; 289(5478):409-11. PubMed ID: 10939953
[No Abstract] [Full Text] [Related]
7. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
8. Applications of neuroreceptor imaging to psychiatry research.
Smith GS; Koppel J; Goldberg S
Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
[TBL] [Abstract][Full Text] [Related]
9. Receptor imaging by positron emission tomography and single-photon emission computed tomography.
Frost JJ
Invest Radiol; 1992 Dec; 27 Suppl 2():S54-8. PubMed ID: 1334949
[TBL] [Abstract][Full Text] [Related]
10. Post-mortem brain tissue cultures from elderly control subjects and patients with a neurodegenerative disease.
Verwer RW; Baker RE; Boiten EF; Dubelaar EJ; van Ginkel CJ; Sluiter AA; Swaab DF
Exp Gerontol; 2003; 38(1-2):167-72. PubMed ID: 12543274
[TBL] [Abstract][Full Text] [Related]
11. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia.
Tanna NK; Kohn MI; Horwich DN; Jolles PR; Zimmerman RA; Alves WM; Alavi A
Radiology; 1991 Jan; 178(1):123-30. PubMed ID: 1984290
[TBL] [Abstract][Full Text] [Related]
12. Imaging of receptors in clinical neurosciences.
Korf J
Acta Neurol Belg; 1997 Sep; 97(3):200-5. PubMed ID: 9345594
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics of human brain aging and age-related neurodegenerative diseases.
Jové M; Portero-Otín M; Naudí A; Ferrer I; Pamplona R
J Neuropathol Exp Neurol; 2014 Jul; 73(7):640-57. PubMed ID: 24918636
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of MR-based partial-volume correction schemes for PET.
Meltzer CC; Kinahan PE; Greer PJ; Nichols TE; Comtat C; Cantwell MN; Lin MP; Price JC
J Nucl Med; 1999 Dec; 40(12):2053-65. PubMed ID: 10616886
[TBL] [Abstract][Full Text] [Related]
15. An introduction to PET and SPECT neuroreceptor quantification models.
Ichise M; Meyer JH; Yonekura Y
J Nucl Med; 2001 May; 42(5):755-63. PubMed ID: 11337572
[TBL] [Abstract][Full Text] [Related]
16. Drug development for neurodegenerative diseases: role of PET.
Rinne JO
Ann Med; 1999 Dec; 31(6):444-9. PubMed ID: 10680860
[TBL] [Abstract][Full Text] [Related]
17. Special issues in quantitation of brain receptors and related markers by emission computed tomography.
Links JM
Q J Nucl Med; 1998 Sep; 42(3):158-65. PubMed ID: 9796364
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the drawbacks of single photon emission computed tomography and positron emission tomography imaging].
Mizumura S
Brain Nerve; 2010 May; 62(5):489-500. PubMed ID: 20450096
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.
Waragai M; Yamada T; Matsuda H
J Neurol Sci; 2007 Sep; 260(1-2):57-64. PubMed ID: 17493637
[TBL] [Abstract][Full Text] [Related]
20. Target-specific PET probes for neurodegenerative disorders related to dementia.
Kadir A; Nordberg A
J Nucl Med; 2010 Sep; 51(9):1418-30. PubMed ID: 20810758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
